Tag: cx 2024
BEST-CLI and the BASIL trials: Motion sees audience move in favor...
During the 2024 Charing Cross (CX) International Symposium in London, England (April 23–25), a Great Debate that pitted four global peripheral arterial disease (PAD)...
The role of deep venous arterialization comes under scrutiny
"Every so often in vascular disease, disruptive technologies come along and the question really is, ‘Is this going to make a big impact on...
Vascular Specialist–May 2024
In this issue:
Questions linger: BASIL-3 does not find for drug-eluting technologies for CLTI
Guest Editorial: Aortas, open surgical skills and gratitude
Vascular training:...
‘Who let a vascular surgeon in the room?’: Leadership in the...
Leading vascular surgeons from across the globe contributed pearls of wisdom on how to go about tackling inevitable turf battles from other specialties practicing...
New randomised data show cyanoacrylate glue performs strongly on patient satisfaction
Patients undergoing cyanoacrylate glue closure for superficial venous disease reported higher periprocedural satisfaction than those who were treated via surgical stripping, data from a...
Interim analysis provides early window into real-world Alto stent graft outcomes
In a podium-first presentation on the final day of the 2024 Charing Cross (CX) International Symposium (23–25 April, London, UK), Sean Lyden (Cleveland Clinic,...
Questions linger: BASIL-3 does not find for drug-eluting technologies for CLTI
In the UK National Institute for Health and Care Research (NIHR) Health Technology Assessment (HTA)-funded BASIL-3 randomised controlled trial (RCT), neither drug-coated balloon (DCB)...
CX united: Vascular world set to converge with challenging cases
The World Federation of Vascular Societies (WFVS) is bringing the vascular world together at CX 2024 to chew over both challenging cases and leadership...
Paclitaxel controversy: Yes, device restrictions did cause harm
“Unfortunately, we are doing worse for our patients today,” were the sobering thoughts of Eric Secemsky (Boston, United States) during a late-breaking presentation in...
Greenhalgh legacy set to continue at CX 2024
Though the 2024 edition of the Charing Cross (CX) International Symposium (April 23–25) in London, England, marks a new era, it will be tinged...
Endovascular showdown: CX 2024 sets the stage for BASIL-3 first-time data...
At the Charing Cross (CX) Symposium 2024 (23–25 April, London, UK), Andrew Bradbury (University of Birmingham, Birmingham, UK) and the BASIL-3 team of triallists...